FDA will no longer require significant warning label with hormone therapies for menopause

Name: FDA will no longer require significant warning label with hormone therapies for menopause
Uploaded: 2025-11-10T18:58:00-0700
Duration: 6 min 7 s
Description: The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to encourage more women to seek treatment.

The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to encourage more women to seek treatment.